| June 2nd, 2017 03:15 PM | |
| Vishal Kotkar | Re: alexion pharmaceuticals inc annual report Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).   Here I am attaching a pdf file of report .alexion.com/2016-Annual-Report/full-report/ Alexion Pharmaceuticals share price (17 may 2017) Open $120.75 Day Range 119.8500 - 121.0950 52 Week Range 109.1200 - 157.0200 Market Cap $27.16B Shares Outstanding 224.56M Public Float 223.24M Beta 1.48 Rev. per Employee $1.03M P/E Ratio 57.56 EPS $2.09 Yield n/a Dividend n/a Ex-Dividend Date n/a Short Interest 4.52M % of Float Shorted 2.03% Average Volume 2.01M Performance 5 Day -0.54% 1 Month -0.16% 3 Month -8.86% YTD -1.68% 1 Year -15.48% |
| June 2nd, 2017 03:12 PM | |
| Unregistered | Re: alexion pharmaceuticals inc annual report I want the Annual Report of Alexion Pharmaceuticals Inc. so can you provide me? |
| July 6th, 2016 10:12 AM | |
| suman | alexion pharmaceuticals inc annual report Discuss about alexion pharmaceuticals inc annual report here. Welcome to Courses.ind.in and this page is for alexion pharmaceuticals inc annual report discussion. If you are looking for information on alexion pharmaceuticals inc annual report then ask your question is as much details as possible in the “Reply” box provided below. The more detailed your question will be, the more easy will it be for our experts to answers your query. And if you have any updated or latest information on alexion pharmaceuticals inc annual report, then please share you knowledge with our experts in the “Reply” box below. Your reply will be published here and your knowledge can help many people. Thanks for stopping by at Courses.ind.in. Please visit again. |
